ARCH Venture Partners' Bob Nelsen and Kristina Burow
ARCH, biotech's star slugger, snags another $3B for 13th fund
Bob Nelsen will tell you that ARCH Venture Partners is always chasing home runs. The early-stage VC firm has backed some of the most recognizable …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
